Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes

✍ Scribed by Giagounidis, Aristoteles; Mufti, Ghulam J.; Fenaux, Pierre; Germing, Ulrich; List, Alan; MacBeth, Kyle J.

• Book ID: 121582938
• Publisher: Springer
• Year: 2013
• Tongue: English
• Weight: 622 KB
• Volume: 93
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s00277-013-1863-5